{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:58:17Z","timestamp":1790218697068,"version":"4.1.0"},"reference-count":278,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.nbd.2011.12.054","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T11:09:01Z","timestamp":1326452941000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["Iron dysregulation in movement disorders"],"prefix":"10.1016","volume":"46","author":[{"given":"Petr","family":"Dusek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.12.054_bb0005","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(07)61782-6","article-title":"Haemochromatosis","volume":"370","author":"Adams","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2011.12.054_bb0010","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/mds.23095","article-title":"Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms","volume":"25","author":"Aggarwal","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1399-0004.2010.01441.x","article-title":"C2orf37 mutational spectrum in Woodhouse\u2013Sakati syndrome patients","volume":"78","author":"Alazami","year":"2010","journal-title":"Clin. Genet."},{"issue":"Suppl. 18","key":"10.1016\/j.nbd.2011.12.054_bb0020","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1002\/mds.21607","article-title":"The role of iron in restless legs syndrome","volume":"22","author":"Allen","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/WNL.56.2.263","article-title":"MRI measurement of brain iron in patients with restless legs syndrome","volume":"56","author":"Allen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ajmg.a.31497","article-title":"Autosomal-recessive syndrome with alopecia, hypogonadism, progressive extra-pyramidal disorder, white matter disease, sensory neural deafness, diabetes mellitus, and low IGF1","volume":"143","author":"Al-Semari","year":"2007","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.nbd.2011.12.054_bb0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/mds.20774","article-title":"Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration","volume":"21","author":"Antonini","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0040","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/mds.23173","article-title":"An magnetic resonance imaging T2*-weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms","volume":"25","author":"Arabia","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0045","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1074\/jbc.274.2.1116","article-title":"Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism","volume":"274","author":"Attieh","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0050","doi-asserted-by":"crossref","first-page":"31679","DOI":"10.1074\/jbc.M805532200","article-title":"Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration","volume":"283","author":"Baraibar","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0055","article-title":"Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders","author":"Bareggi","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2011.12.054_bb0060","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","article-title":"Blood\u2013brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration","volume":"30","author":"Bartels","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.054_bb0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archneur.56.5.569","article-title":"Increased basal ganglia iron levels in Huntington disease","volume":"56","author":"Bartzokis","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0070","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neurobiolaging.2006.02.005","article-title":"Brain ferritin iron may influence age- and gender-related risks of neurodegeneration","volume":"28","author":"Bartzokis","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.054_bb0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/JAD-2010-1368","article-title":"Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men","volume":"20","author":"Bartzokis","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2011.12.054_bb0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1741-7015-9-112","article-title":"Friedreich's ataxia: the vicious circle hypothesis revisited","volume":"9","author":"Bayot","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.nbd.2011.12.054_bb0090","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/mds.21020","article-title":"Iron metabolism in Parkinsonian syndromes","volume":"21","author":"Berg","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002340050002","article-title":"The basal ganglia in haemochromatosis","volume":"42","author":"Berg","year":"2000","journal-title":"Neuroradiology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0047-6374(80)90121-9","article-title":"Studies of human myelin proteins during old age","volume":"14","author":"Berlet","year":"1980","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.nbd.2011.12.054_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2006-12-065433","article-title":"Selective iron chelation in Friedreich ataxia: biologic and clinical implications","volume":"110","author":"Boddaert","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.nbd.2011.12.054_bb0110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00415-002-0704-6","article-title":"Association study between iron-related genes polymorphisms and Parkinson's disease","volume":"249","author":"Borie","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0115","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1111\/j.1742-4658.2008.06709.x","article-title":"Emerging pathways in genetic Parkinson's disease: potential role of ceramide metabolism in Lewy body disease","volume":"275","author":"Bras","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2011.12.054_bb0120","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archneurol.2010.281","article-title":"Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype","volume":"67","author":"Bruggemann","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0125","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1111\/j.1468-1331.2010.03298.x","article-title":"Idiopathic NBIA \u2014 clinical spectrum and transcranial sonography findings","volume":"18","author":"Bruggemann","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0130","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/jnr.1256","article-title":"Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat","volume":"66","author":"Burdo","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000279305","article-title":"Multiple sclerosis and the accumulation of iron in the basal ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry","volume":"63","author":"Burgetova","year":"2010","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0140","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbadis.2011.03.018","article-title":"GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings","volume":"1812","author":"Caciotti","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2011.12.054_bb0145","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1089\/gtmb.2010.0076","article-title":"Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patients","volume":"14","author":"Castiglioni","year":"2010","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.nbd.2011.12.054_bb0150","first-page":"827693","article-title":"Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders","volume":"2011","author":"Castiglioni","year":"2010","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.nbd.2011.12.054_bb0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.22435","article-title":"Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis","volume":"70","author":"Catoire","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2006.03.001","article-title":"Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species","volume":"82","author":"Chan","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0165","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00702-009-0234-9","article-title":"Eye of the tiger-like MRI in parkinsonian variant of multiple system atrophy","volume":"116","author":"Chang","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.12.054_bb0170","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.21980","article-title":"High brain iron level in asymptomatic carriers of heterozygous ceruloplasmin gene mutations","volume":"23","author":"Chen","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0175","doi-asserted-by":"crossref","first-page":"33380","DOI":"10.1074\/jbc.M111.268409","article-title":"Enhanced autophagy from chronic toxicity of iron and mutant A53T alpha-synuclein: implications for neuronal cell death in Parkinson disease","volume":"286","author":"Chew","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0031-1285925","article-title":"The \u201ceye-of-the-tiger\u201d sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration","volume":"42","author":"Chiapparini","year":"2011","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nbd.2011.12.054_bb0185","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mds.23514","article-title":"ATP13A2-related neurodegeneration (PARK9) without evidence of brain iron accumulation","volume":"26","author":"Chien","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/brain\/awl319","article-title":"Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation","volume":"130","author":"Chinnery","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.054_bb0195","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/mds.23465","article-title":"Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging","volume":"26","author":"Cho","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0306-4522(90)90320-4","article-title":"Altered cellular distribution of iron in the central nervous system of myelin deficient rats","volume":"34","author":"Connor","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.054_bb0205","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jnr.490270421","article-title":"Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains","volume":"27","author":"Connor","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb0210","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-2001-3506","article-title":"Is hemochromatosis a risk factor for Alzheimer's disease?","volume":"3","author":"Connor","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2011.12.054_bb0215","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/01.WNL.0000078887.16593.12","article-title":"Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome","volume":"61","author":"Connor","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0220","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/01.WNL.0000123251.60485.AC","article-title":"Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome","volume":"62","author":"Connor","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0225","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/brain\/awr012","article-title":"Profile of altered brain iron acquisition in restless legs syndrome","volume":"134","author":"Connor","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.054_bb0230","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U","article-title":"Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes","volume":"45","author":"Cossee","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0235","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jnnp.2003.027441","article-title":"Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series","volume":"75","author":"Costello","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.054_bb0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2009.09.009","article-title":"Oxidative stress and cell death in cells expressing l-ferritin variants causing neuroferritinopathy","volume":"37","author":"Cozzi","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.054_bb0245","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00702-010-0470-z","article-title":"Brain iron metabolism and its perturbation in neurological diseases","volume":"118","author":"Crichton","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.12.054_bb0250","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ng571","article-title":"Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease","volume":"28","author":"Curtis","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0255","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1620\/tjem.191.119","article-title":"A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM)","volume":"191","author":"Daimon","year":"2000","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.nbd.2011.12.054_bb0260","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3174\/ajnr.A1508","article-title":"MR imaging findings in 2 cases of late infantile GM1 gangliosidosis","volume":"30","author":"De Grandis","year":"2009","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0265","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/1531-8249(199905)45:5<673::AID-ANA20>3.0.CO;2-Q","article-title":"Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia","volume":"45","author":"Delatycki","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2010.05.025","article-title":"Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy","volume":"479","author":"Deng","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.12.054_bb0275","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1093\/brain\/awn274","article-title":"Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation","volume":"132","author":"Devos","year":"2009","journal-title":"Brain"},{"issue":"Pt. 4","key":"10.1016\/j.nbd.2011.12.054_bb0280","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.054_bb0285","doi-asserted-by":"crossref","first-page":"E1251","DOI":"10.1002\/humu.21205","article-title":"Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35)","volume":"31","author":"Dick","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2011.12.054_bb0290","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nature07311","article-title":"The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel","volume":"455","author":"Dong","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.12.054_bb0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2214\/ajr.147.1.103","article-title":"MRI of brain iron","volume":"147","author":"Drayer","year":"1986","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0300","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2214\/ajr.149.2.357","article-title":"Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?","volume":"149","author":"Drayer","year":"1987","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0305","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/mds.23643","article-title":"Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease","volume":"26","author":"Du","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0310","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0006-8993(90)90950-G","article-title":"An autoradiographic study of the uptake and distribution of iron by the brain of the young rat","volume":"518","author":"Dwork","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb0315","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ajhg.2008.10.010","article-title":"Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia","volume":"83","author":"Edvardson","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0320","article-title":"Novel mutation in ATP13A2 widens the spectrum of Kufor\u2013Rakeb syndrome (PARK9)","author":"Eiberg","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0325","doi-asserted-by":"crossref","first-page":"e12897","DOI":"10.1371\/journal.pone.0012897","article-title":"Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism","volume":"5","author":"Engel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2011.12.054_bb0330","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10072-011-0589-1","article-title":"The \u201ceye of the tiger\u201d sign in pure akinesia with gait freezing","volume":"32","author":"Erro","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.12.054_bb0335","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00415-005-0695-1","article-title":"Association study of the G258S transferrin gene polymorphism and Parkinson's disease in the Spanish population","volume":"252","author":"Ezquerra","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0340","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","article-title":"Blood\u2013brain barrier: ageing and microvascular disease\u2014systematic review and meta-analysis","volume":"30","author":"Farrall","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.054_bb0345","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mds.21938","article-title":"Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability","volume":"23","author":"Fasano","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0350","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1073\/pnas.92.21.9603","article-title":"Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease","volume":"92","author":"Faucheux","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.054_bb0355","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","article-title":"Blood vessels change in the mesencephalon of patients with Parkinson's disease","volume":"353","author":"Faucheux","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2011.12.054_bb0360","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1471-4159.2002.01118.x","article-title":"Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease","volume":"83","author":"Faucheux","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0365","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1046\/j.1471-4159.2003.01923.x","article-title":"Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease","volume":"86","author":"Faucheux","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0370","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis","volume":"13","author":"Feder","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0375","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/mds.870080311","article-title":"Axial motor disturbances after hypoxic lesions of the globus pallidus","volume":"8","author":"Feve","year":"1993","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0380","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jhep.2010.04.039","article-title":"Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation","volume":"53","author":"Finkenstedt","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0385","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jnr.490180206","article-title":"Receptor-mediated transcytosis of transferrin across the blood\u2013brain barrier","volume":"18","author":"Fishman","year":"1987","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb0390","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1182\/asheducation-2011.1.525","article-title":"Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation","volume":"2011","author":"Fleming","year":"2011","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.nbd.2011.12.054_bb0395","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.22002","article-title":"Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation","volume":"23","author":"Forni","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0400","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mds.22769","article-title":"Restless legs syndrome in Friedreich ataxia: a polysomnographic study","volume":"26","author":"Frauscher","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0405","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.51.2.565","article-title":"Mucolipidosis type IV: characteristic MRI findings","volume":"51","author":"Frei","year":"1998","journal-title":"Neurology"},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2011.12.054_bb0410","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1016\/S1353-8020(09)70817-X","article-title":"Iron as a cause of Parkinson disease \u2014 a myth or a well established hypothesis?","volume":"15","author":"Friedman","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0415","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.parkreldis.2011.03.016","article-title":"Ferritin as an important player in neurodegeneration","volume":"17","author":"Friedman","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0420","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1073\/pnas.0911177107","article-title":"Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast","volume":"107","author":"Fukunaga","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.054_bb0425","first-page":"777","article-title":"MR brain imaging of fucosidosis type I","volume":"22","author":"Galluzzi","year":"2001","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0430","first-page":"347","article-title":"Hepcidin and disorders of iron metabolism","volume":"Vol. 62","author":"Ganz","year":"2011"},{"key":"10.1016\/j.nbd.2011.12.054_bb0435","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/mds.23256","article-title":"Restless legs syndrome and Parkinson's disease in men","volume":"25","author":"Gao","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0440","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1469-8749.2011.03993.x","article-title":"FA2H-related disorders: a novel c.270+3A>T splice-site mutation leads to a complex neurodegenerative phenotype","volume":"53","author":"Garone","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0445","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00702-010-0503-7","article-title":"Iron-dependent functions of mitochondria\u2014relation to neurodegeneration","volume":"118","author":"Gille","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.12.054_bb0450","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng.300","article-title":"Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity","volume":"41","author":"Gitler","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0455","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/mds.22070","article-title":"Multiregional brain iron deficiency in restless legs syndrome","volume":"23","author":"Godau","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0460","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0891-5849(93)90043-T","article-title":"The Fenton reagents","volume":"15","author":"Goldstein","year":"1993","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2011.12.054_bb0465","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1440-1789.2008.00901.x","article-title":"Redox active iron accumulation in aceruloplasminemia","volume":"28","author":"Gonzalez-Cuyar","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0470","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(92)91334-B","article-title":"Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study","volume":"593","author":"Good","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb0475","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.45.6.1138","article-title":"Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease","volume":"45","author":"Gorell","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0480","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s11910-011-0181-3","article-title":"Genetics of neurodegeneration with brain iron accumulation","volume":"11","author":"Gregory","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.nbd.2011.12.054_bb0485","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.wnl.0000327094.67726.28","article-title":"Neurodegeneration associated with genetic defects in phospholipase A(2)","volume":"71","author":"Gregory","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0490","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2008.061929","article-title":"Clinical and genetic delineation of neurodegeneration with brain iron accumulation","volume":"46","author":"Gregory","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0495","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00234-010-0677-6","article-title":"Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism","volume":"52","author":"Gupta","year":"2010","journal-title":"Neuroradiology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0500","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.1958.tb12607.x","article-title":"The effect of age on the non-haemin iron in the human brain","volume":"3","author":"Hallgren","year":"1958","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0505","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2009.12.004","article-title":"Fatty acid 2-hydroxylation in mammalian sphingolipid biology","volume":"1801","author":"Hama","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2011.12.054_bb0510","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1073\/pnas.92.7.2539","article-title":"Aceruloplasminemia: molecular characterization of this disorder of iron metabolism","volume":"92","author":"Harris","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.054_bb0515","doi-asserted-by":"crossref","first-page":"10812","DOI":"10.1073\/pnas.96.19.10812","article-title":"Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux","volume":"96","author":"Harris","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.054_bb0520","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.20771","article-title":"Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation","volume":"59","author":"Hartig","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0525","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ajhg.2011.09.007","article-title":"Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation","volume":"89","author":"Hartig","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0530","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa020817","article-title":"Genetic, clinical, and radiographic delineation of Hallervorden\u2013Spatz syndrome","volume":"348","author":"Hayflick","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2011.12.054_bb0535","first-page":"1230","article-title":"Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations","volume":"27","author":"Hayflick","year":"2006","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0540","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2011.07.001","article-title":"DMT1 polymorphism and risk of Parkinson's disease","volume":"501","author":"He","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.12.054_bb0545","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp.70.1.65","article-title":"X-linked sideroblastic anaemia with ataxia: another mitochondrial disease?","volume":"70","author":"Hellier","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.054_bb0550","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jns.2010.08.019","article-title":"Aceruloplasminemia in a Japanese woman with a novel mutation of CP gene: clinical presentations and analysis of genetic and molecular pathogenesis","volume":"298","author":"Hida","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.12.054_bb0555","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/hmg\/9.19.2789","article-title":"Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles","volume":"9","author":"Hilditch-Maguire","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0560","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1212\/01.WNL.0000144276.29988.C3","article-title":"Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease","volume":"63","author":"Hochstrasser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0565","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-510X(02)00321-0","article-title":"Movement disorders in Friedreich's ataxia","volume":"206","author":"Hou","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.12.054_bb0570","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.WNL.0000094120.09977.92","article-title":"Compound heterozygous PANK2 mutations confirm HARP and Hallervorden\u2013Spatz syndromes are allelic","volume":"61","author":"Houlden","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0575","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00221-005-0220-x","article-title":"Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury","volume":"170","author":"Huang","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb0580","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1651-2227.1999.tb01087.x","article-title":"Fucosidosis: immunological studies and chronological neuroradiological changes","volume":"88","author":"Ismail","year":"1999","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.nbd.2011.12.054_bb0585","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2008.12.010","article-title":"Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death","volume":"278","author":"Jana","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.12.054_bb0590","doi-asserted-by":"crossref","first-page":"27144","DOI":"10.1074\/jbc.M301988200","article-title":"Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system","volume":"278","author":"Jeong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0595","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2009.01.015","article-title":"Critical role of iron in the pathogenesis of the murine gangliosidoses","volume":"34","author":"Jeyakumar","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.054_bb0600","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuint.2007.03.006","article-title":"Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra","volume":"51","author":"Jiang","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2011.12.054_bb0605","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/brain\/awq319","article-title":"Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease","volume":"134","author":"Jin","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.054_bb0610","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10495-009-0452-5","article-title":"Regulation of apoptosis-associated lysosomal membrane permeabilization","volume":"15","author":"Johansson","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.nbd.2011.12.054_bb0615","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/088307380001500904","article-title":"Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies","volume":"15","author":"Johnston","year":"2000","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0620","article-title":"Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness","author":"Kaneko","year":"2011","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0625","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","article-title":"Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?","volume":"59","author":"Kastner","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0630","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.freeradbiomed.2008.11.012","article-title":"Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: implications for Parkinson's disease","volume":"46","author":"Kaur","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2011.12.054_bb0635","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/mds.23851","article-title":"The PLA2G6 gene in early-onset Parkinson's disease","volume":"26","author":"Kauther","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0640","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pneurobio.2007.07.009","article-title":"Brain iron metabolism: neurobiology and neurochemistry","volume":"83","author":"Ke","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0645","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00204-010-0577-x","article-title":"Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples","volume":"84","author":"Kell","year":"2010","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0650","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1086\/508572","article-title":"PLA2G6 mutation underlies infantile neuroaxonal dystrophy","volume":"79","author":"Khateeb","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0655","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2004.12.061","article-title":"Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease","volume":"379","author":"Klopstock","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.12.054_bb0660","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00401-007-0220-y","article-title":"The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins","volume":"114","author":"Koeppen","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0665","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12311-010-0235-0","article-title":"The neuropathology of late-onset Friedreich's ataxia","volume":"10","author":"Koeppen","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2011.12.054_bb0670","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4067\/S0716-97602006000100003","article-title":"Molecular and pathological basis of aceruloplasminemia","volume":"39","author":"Kono","year":"2006","journal-title":"Biol. Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb0675","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.bbadis.2010.07.011","article-title":"Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin","volume":"1802","author":"Kono","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2011.12.054_bb0680","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.22122","article-title":"Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA)","volume":"68","author":"Kruer","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0685","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/brain\/awr042","article-title":"Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration","volume":"134","author":"Kruer","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.054_bb0690","article-title":"Neuroimaging features of neurodegeneration with brain iron accumulation","author":"Kruer","year":"2011","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0695","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/mds.22435","article-title":"A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype\u2013phenotype correlations","volume":"24","author":"Kubota","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0700","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.braindev.2007.01.001","article-title":"Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate","volume":"29","author":"Kuhn","year":"2007","journal-title":"Brain Dev."},{"key":"10.1016\/j.nbd.2011.12.054_bb0705","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/archneur.63.2.292","article-title":"The \u201ceye-of-the-tiger\u201d sign is not pathognomonic of the PANK2 mutation","volume":"63","author":"Kumar","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0710","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1212\/01.wnl.0000310986.48286.8e","article-title":"Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN)","volume":"70","author":"Kurian","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0715","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1469-8749.2011.03955.x","article-title":"Childhood disorders of neurodegeneration with brain iron accumulation (NBIA)","volume":"53","author":"Kurian","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0720","first-page":"293","article-title":"Multiple system atrophy with a-\/hypo-ceruloplasminemia: distribution of iron in brains of 2 autopsy cases","volume":"42","author":"Kurisaki","year":"2002","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.nbd.2011.12.054_bb0725","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.biocel.2011.08.016","article-title":"The role of lysosomes in iron metabolism and recycling","volume":"43","author":"Kurz","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0730","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.parkreldis.2011.06.024","article-title":"Long-term improvement under deferiprone in a case of neurodegeneration with brain iron accumulation","volume":"18","author":"Kwiatkowski","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0735","doi-asserted-by":"crossref","first-page":"29065","DOI":"10.1074\/jbc.M109.000638","article-title":"Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease","volume":"284","author":"Lee","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0740","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.wnl.0000265228.66664.f4","article-title":"Clinical heterogeneity of ATP13A2 linked disease (Kufor\u2013Rakeb) justifies a PARK designation","volume":"68","author":"Lees","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0745","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biochi.2010.01.005","article-title":"Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death","volume":"92","author":"Lei","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.nbd.2011.12.054_bb0750","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbagen.2008.09.008","article-title":"The role of iron in mitochondrial function","volume":"1790","author":"Levi","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2011.12.054_bb0755","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00702-010-0518-0","article-title":"Iron chelation and neuroprotection in neurodegenerative diseases","volume":"118","author":"Li","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.12.054_bb0760","article-title":"Pantothenate kinase-associated neurodegeneration in Korea: recurrent R440P mutation in PANK2 and outcome of deep brain stimulation","author":"Lim","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0765","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1468-1331.2009.02733.x","article-title":"Hypoceruloplasminemia-related movement disorder without Kayser\u2013Fleischer rings is different from Wilson disease and not involved in ATP7B mutation","volume":"16","author":"Lirong","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0770","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.gene.2005.04.040","article-title":"Increased IRP1 activity in Friedreich ataxia","volume":"354","author":"Lobmayr","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.nbd.2011.12.054_bb0775","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0168-8278(02)00042-9","article-title":"Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights","volume":"36","author":"Loreal","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0780","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/01.wnl.0000178224.81169.c2","article-title":"Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement","volume":"65","author":"Maciel","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0785","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1469-8749.2010.03815.x","article-title":"Cognitive functioning in children with pantothenate-kinase-associated neurodegeneration undergoing deep brain stimulation","volume":"53","author":"Mahoney","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0790","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2353\/ajpath.2008.070823","article-title":"Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations","volume":"172","author":"Malik","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0795","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnen\/64.4.280","article-title":"Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights","volume":"64","author":"Mancuso","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0800","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/gut.2003.030429","article-title":"Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation","volume":"53","author":"Mariani","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.nbd.2011.12.054_bb0805","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.brainresrev.2011.04.001","article-title":"Friedreich's ataxia: past, present and future","volume":"67","author":"Marmolino","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.nbd.2011.12.054_bb0810","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2009.02.009","article-title":"A novel transferrin\/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease","volume":"34","author":"Mastroberardino","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.054_bb0815","doi-asserted-by":"crossref","first-page":"28614","DOI":"10.1074\/jbc.M400977200","article-title":"Ceramide-induced intracellular oxidant formation, iron signaling, and apoptosis in endothelial cells: protective role of endogenous nitric oxide","volume":"279","author":"Matsunaga","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.054_bb0820","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/B978-0-444-52014-2.00009-4","article-title":"Neurodegeneration with brain iron accumulation","volume":"100","author":"McNeill","year":"2011","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0825","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/01.wnl.0000310985.40011.d6","article-title":"T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation","volume":"70","author":"McNeill","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0830","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000148691","article-title":"The neurological presentation of ceruloplasmin gene mutations","volume":"60","author":"McNeill","year":"2008","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0835","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14734220600913246","article-title":"Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia","volume":"5","author":"Michael","year":"2006","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2011.12.054_bb0840","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/mds.20280","article-title":"Adult-onset generalized dystonia due to a mutation in the neuroferritinopathy gene","volume":"20","author":"Mir","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0845","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1440-1789.2003.00521.x","article-title":"Aceruloplasminemia, an iron metabolic disorder","volume":"23","author":"Miyajima","year":"2003","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0850","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1212\/WNL.37.5.761","article-title":"Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration","volume":"37","author":"Miyajima","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0855","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ana.410410318","article-title":"Use of desferrioxamine in the treatment of aceruloplasminemia","volume":"41","author":"Miyajima","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0860","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.53.3.617","article-title":"Estimation of the gene frequency of aceruloplasminemia in Japan","volume":"53","author":"Miyajima","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0865","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1212\/WNL.57.12.2205","article-title":"Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation","volume":"57","author":"Miyajima","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0870","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1020775101654","article-title":"Aceruloplasminemia, an inherited disorder of iron metabolism","volume":"16","author":"Miyajima","year":"2003","journal-title":"Biometals"},{"key":"10.1016\/j.nbd.2011.12.054_bb0875","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ng1826","article-title":"PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron","volume":"38","author":"Morgan","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb0880","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000147312","article-title":"Histochemical distribution of non-haem iron in the human brain","volume":"144","author":"Morris","year":"1992","journal-title":"Acta Anat. (Basel)"},{"key":"10.1016\/j.nbd.2011.12.054_bb0885","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/1479-7364-5-6-577","article-title":"Human genetics and genomics a decade after the release of the draft sequence of the human genome","volume":"5","author":"Naidoo","year":"2011","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.nbd.2011.12.054_bb0890","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0404.1994.tb02645.x","article-title":"Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor\u2013Rakeb syndrome","volume":"89","author":"Najim al-Din","year":"1994","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2011.12.054_bb0895","doi-asserted-by":"crossref","first-page":"729S","DOI":"10.3945\/jn.110.130351","article-title":"HFE gene variants affect iron in the brain","volume":"141","author":"Nandar","year":"2011","journal-title":"J. Nutr."},{"key":"10.1016\/j.nbd.2011.12.054_bb0900","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","article-title":"Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model","volume":"102","author":"Nguyen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.054_bb0905","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/jnnp.59.3.318","article-title":"Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome","volume":"59","author":"Nielsen","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.054_bb0910","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2169\/internalmedicine.50.5108","article-title":"Criteria for early identification of aceruloplasminemia","volume":"50","author":"Ogimoto","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.nbd.2011.12.054_bb0915","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/01.wnl.0000310428.74624.95","article-title":"Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene","volume":"70","author":"Ohta","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0920","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2990.2006.00710.x","article-title":"Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia","volume":"32","author":"Oide","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0925","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.sleep.2009.12.002","article-title":"Intravenous iron dextran for severe refractory restless legs syndrome","volume":"11","author":"Ondo","year":"2010","journal-title":"Sleep Med."},{"key":"10.1016\/j.nbd.2011.12.054_bb0930","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/mds.23299","article-title":"Dramatic response of facial stereotype\/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States","volume":"25","author":"Ondo","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0935","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s00247-007-0572-4","article-title":"Fucosidosis: MRI and MRS findings","volume":"37","author":"Oner","year":"2007","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0940","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/mds.22669","article-title":"Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC)","volume":"24","author":"Ory-Magne","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0945","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1148\/radiol.10091742","article-title":"Assessment of brain white matter fiber bundle atrophy in patients with Friedreich ataxia","volume":"255","author":"Pagani","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0950","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.21415","article-title":"Characterization of PLA2G6 as a locus for dystonia-parkinsonism","volume":"65","author":"Paisan-Ruiz","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0955","article-title":"Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations","author":"Paisan-Ruiz","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.054_bb0960","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/mds.23797","article-title":"Desferrioxamine treatment of aceruloplasminemia: long-term follow-up","volume":"26","author":"Pan","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb0965","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy\u2013Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.12.054_bb0970","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/humu.21527","article-title":"Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor\u2013Rakeb syndrome, a form of early-onset parkinsonism","volume":"32","author":"Park","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2011.12.054_bb0975","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1212\/01.WNL.0000161843.52641.EC","article-title":"The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration","volume":"64","author":"Pellecchia","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb0980","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1093\/brain\/awq212","article-title":"Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature","volume":"133","author":"Peran","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.054_bb0985","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ana.410180411","article-title":"Hallervorden\u2013Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus","volume":"18","author":"Perry","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb0990","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nbd.2010.04.009","article-title":"Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation","volume":"39","author":"Poli","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.054_bb0995","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jinorgbio.2007.03.004","article-title":"The chemical form of mitochondrial iron in Friedreich's ataxia","volume":"101","author":"Popescu","year":"2007","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.nbd.2011.12.054_bb1000","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","article-title":"Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction","volume":"584","author":"Posse de Chaves","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2011.12.054_bb1005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/glia.21172","article-title":"Central nervous system dysfunction in a mouse model of FA2H deficiency","volume":"59","author":"Potter","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2011.12.054_bb1010","first-page":"809","article-title":"Neuroradiologic findings in fucosidosis, a rare lysosomal storage disease","volume":"16","author":"Provenzale","year":"1995","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/84818","article-title":"Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe\u2013S enzyme deficiency followed by intramitochondrial iron deposits","volume":"27","author":"Puccio","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb1020","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/jcp.22485","article-title":"Divalent metal transporter 1 is a hypoxia-inducible gene","volume":"226","author":"Qian","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/mds.22399","article-title":"Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease","volume":"24","author":"Rakovic","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb1030","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb1035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2008.07.001","article-title":"Genetics of iron regulation and the possible role of iron in Parkinson's disease","volume":"32","author":"Rhodes","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.054_bb1040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains","volume":"52","author":"Riederer","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.054_bb1045","doi-asserted-by":"crossref","first-page":"12239","DOI":"10.1073\/pnas.220403797","article-title":"Frataxin activates mitochondrial energy conversion and oxidative phosphorylation","volume":"97","author":"Ristow","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.054_bb1050","article-title":"Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation","author":"Rossi","year":"2011","journal-title":"Brain Dev."},{"key":"10.1016\/j.nbd.2011.12.054_bb1055","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00415-004-0445-9","article-title":"Hereditary haemochromatosis is unlikely to cause movement disorders\u2014a critical review","volume":"251","author":"Russo","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1060","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","article-title":"Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease","volume":"105","author":"Salazar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.054_bb1065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10048-010-0259-0","article-title":"Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability","volume":"12","author":"Santoro","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nbd.2011.12.054_bb1070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0306-4522(94)00618-F","article-title":"Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum\/globus pallidus complex","volume":"67","author":"Sastry","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.054_bb1075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/nbm.922","article-title":"High-field magnetic resonance imaging of brain iron: birth of a biomarker?","volume":"17","author":"Schenck","year":"2004","journal-title":"NMR Biomed."},{"key":"10.1016\/j.nbd.2011.12.054_bb1080","article-title":"Neurodegeneration with brain iron accumulation \u2014 clinical syndromes and neuroimaging","author":"Schipper","year":"2011","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.nbd.2011.12.054_bb1085","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.21886","article-title":"Dystonia in the Woodhouse Sakati syndrome: a new family and literature review","volume":"23","author":"Schneider","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb1090","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.22211","article-title":"Three faces of the same gene: FA2H links neurodegeneration with brain iron accumulation, leukodystrophies, and hereditary spastic paraplegias","volume":"68","author":"Schneider","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1095","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22947","article-title":"ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation","volume":"25","author":"Schneider","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb1100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mds.23971","article-title":"Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations","volume":"27","author":"Schneider","year":"2011","journal-title":"Mov. Disord."},{"issue":"Pt. 12","key":"10.1016\/j.nbd.2011.12.054_bb1105","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/120.12.2131","article-title":"Friedreich's ataxia. Revision of the phenotype according to molecular genetics","volume":"120","author":"Schols","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.054_bb1110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.expneurol.2009.04.005","article-title":"Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation","volume":"218","author":"Schonberg","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1115","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s11064-007-9378-x","article-title":"Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells","volume":"32","author":"Schonfeld","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb1120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp.60.1.98","article-title":"Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy","volume":"60","author":"Schwarz","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.054_bb1125","doi-asserted-by":"crossref","first-page":"101e1","DOI":"10.1016\/j.genhosppsych.2011.04.013","article-title":"Hemochromatosis-induced bipolar disorder: a case report","volume":"34","author":"Serata","year":"2012","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.054_bb1130","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.23774","article-title":"Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond","volume":"26","author":"Shachar","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb1135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s100380050051","article-title":"Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia","volume":"43","author":"Shimada","year":"1998","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb1140","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","article-title":"The relevance of iron in the pathogenesis of Parkinson's disease","volume":"118","author":"Sian-Hulsmann","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.054_bb1145","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","article-title":"Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease","volume":"55","author":"Simmons","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2011.12.054_bb1150","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/NEN.0b013e3181bdc44f","article-title":"Mitochondrial ferritin in the substantia nigra in restless legs syndrome","volume":"68","author":"Snyder","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1155","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/brain\/awq257","article-title":"Magnetic resonance imaging pattern recognition in hypomyelinating disorders","volume":"133","author":"Steenweg","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.054_bb1160","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1468-1331.2007.01925.x","article-title":"Eye of the tiger sign in multiple system atrophy","volume":"14","author":"Strecker","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12311-010-0215-4","article-title":"Restless legs and substantia nigra hypoechogenicity are common features in Friedreich's ataxia","volume":"10","author":"Synofzik","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2011.12.054_bb1170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ana.21663","article-title":"PLA2G6 mutations and Parkinson's disease","volume":"67","author":"Tan","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1175","doi-asserted-by":"crossref","first-page":"29654","DOI":"10.1074\/jbc.M111.233874","article-title":"Regulation of intracellular manganese homeostasis by Kufor\u2013Rakeb syndrome-associated ATP13A2 protein","volume":"286","author":"Tan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.054_bb1180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-3806(90)90103-6","article-title":"Developmental changes in transferrin and iron uptake by the brain in the rat","volume":"55","author":"Taylor","year":"1990","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.054_bb1185","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00257907","article-title":"Role of transferrin in iron uptake by the brain: a comparative study","volume":"161","author":"Taylor","year":"1991","journal-title":"J. Comp. Physiol. B"},{"key":"10.1016\/j.nbd.2011.12.054_bb1190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.10650","article-title":"Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden\u2013Spatz syndrome) and pantothenate kinase-associated neurodegeneration","volume":"19","author":"Thomas","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb1195","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awq022","article-title":"Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation","volume":"133","author":"Timmermann","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.054_bb1200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/glia.20784","article-title":"Oligodendrocytes and myelination: the role of iron","volume":"57","author":"Todorich","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2011.12.054_bb1205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/jhg.2011.22","article-title":"PLA2G6 variant in Parkinson's disease","volume":"56","author":"Tomiyama","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb1210","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00702-006-0452-3","article-title":"Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle","volume":"113","author":"Tribl","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.12.054_bb1215","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1074\/mcp.M900006-MCP200","article-title":"Identification of l-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach","volume":"8","author":"Tribl","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2011.12.054_bb1220","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.054_bb1225","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/mds.23217","article-title":"Hallervorden\u2013Spatz disease: historical case presentation in the spotlight of nosological evolution","volume":"25","author":"Van Craenenbroeck","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb1230","article-title":"Handedness correlates with the dominant parkinson side: a systematic review and meta-analysis","author":"van der Hoorn","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb1235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/abbi.2000.1952","article-title":"Intact human ceruloplasmin is required for the incorporation of iron into human ferritin","volume":"381","author":"Van Eden","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.nbd.2011.12.054_bb1240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12311-010-0212-7","article-title":"Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia","volume":"10","author":"Velasco-Sanchez","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2011.12.054_bb1245","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnen\/63.4.363","article-title":"Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene","volume":"63","author":"Vidal","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jmri.20830","article-title":"Relaxation and susceptibility MRI characteristics in Hallervorden\u2013Spatz syndrome","volume":"25","author":"Vinod Desai","year":"2007","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nbd.2011.12.054_bb1255","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1148\/radiology.211.2.r99ma53489","article-title":"T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content","volume":"211","author":"Vymazal","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.nbd.2011.12.054_bb1260","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jns.2007.05.018","article-title":"MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters","volume":"263","author":"Vymazal","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.12.054_bb1265","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2353\/ajpath.2009.090343","article-title":"Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6","volume":"175","author":"Wada","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1270","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2011.06.006","article-title":"Mucolipidosis type IV: an update","volume":"104","author":"Wakabayashi","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2011.12.054_bb1275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H","article-title":"Increased iron in the dentate nucleus of patients with Friedrich's ataxia","volume":"46","author":"Waldvogel","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1280","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/jmri.21563","article-title":"MRI assessment of basal ganglia iron deposition in Parkinson's disease","volume":"28","author":"Wallis","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nbd.2011.12.054_bb1285","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/mds.20628","article-title":"Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease","volume":"20","author":"Walshe","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.054_bb1290","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1111\/j.1460-9568.2007.05515.x","article-title":"Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.054_bb1295","article-title":"Different iron-deposition patterns of multiple system atrophy with predominant Parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging","author":"Wang","year":"2011","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1300","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21465","article-title":"Multiple system atrophy: a primary oligodendrogliopathy","volume":"64","author":"Wenning","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1305","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF02260941","article-title":"Intranigral injected iron progressively reduces striatal dopamine metabolism","volume":"8","author":"Wesemann","year":"1994","journal-title":"J. Neural. Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.nbd.2011.12.054_bb1310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ajmg.1320380125","article-title":"Fucosidosis revisited: a review of 77 patients","volume":"38","author":"Willems","year":"1991","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb1315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1471-4159.2011.07536.x","article-title":"Pathogenic implications of iron accumulation in multiple sclerosis","volume":"120","author":"Williams","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.054_bb1320","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/archophthalmol.2011.309","article-title":"Aceruloplasminemia: retinal histopathologic manifestations and iron-mediated melanosome degradation","volume":"129","author":"Wolkow","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1325","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/jmg.20.3.216","article-title":"A syndrome of hypogonadism, alopecia, diabetes mellitus, mental retardation, deafness, and ECG abnormalities","volume":"20","author":"Woodhouse","year":"1983","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb1330","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1468-1331.2008.02397.x","article-title":"Clinical study and PLA2G6 mutation screening analysis in Chinese patients with infantile neuroaxonal dystrophy","volume":"16","author":"Wu","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1335","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuint.2010.05.008","article-title":"Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells","volume":"57","author":"Wu","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2011.12.054_bb1340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuroimage.2007.11.017","article-title":"Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study","volume":"40","author":"Xu","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2011.12.054_bb1345","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.neuroimage.2008.10.029","article-title":"Susceptibility contrast in high field MRI of human brain as a function of tissue iron content","volume":"44","author":"Yao","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2011.12.054_bb1350","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/WNL.0b013e3181f73649","article-title":"Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism","volume":"75","author":"Yoshino","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.054_bb1355","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","article-title":"Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes","volume":"76","author":"Zecca","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.054_bb1360","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00401-008-0361-7","article-title":"Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease","volume":"116","author":"Zecca","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.12.054_bb1365","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/ars.2010.3129","article-title":"Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit","volume":"13","author":"Zhang","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2011.12.054_bb1370","doi-asserted-by":"crossref","first-page":"e26991","DOI":"10.1371\/journal.pone.0026991","article-title":"Genetic ablation of PLA2G6 in mice leads to cerebellar atrophy characterized by Purkinje cell loss and glial cell activation","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2011.12.054_bb1375","article-title":"Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases","author":"Zheng","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2011.12.054_bb1380","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng572","article-title":"A novel pantothenate kinase gene (PANK2) is defective in Hallervorden\u2013Spatz syndrome","volume":"28","author":"Zhou","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.054_bb1385","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1523\/JNEUROSCI.0458-08.2008","article-title":"Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration","volume":"28","author":"Zoller","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.054_bb1390","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/mds.23751","article-title":"Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial","volume":"26","author":"Zorzi","year":"2011","journal-title":"Mov. Disord."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:07:56Z","timestamp":1760850476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996112000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":278,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0969996112000095"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.12.054","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron dysregulation in movement disorders","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2011.12.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}